The correlation between patent ductus arteriosus and B-type natriuretic peptide as weel as N-terminalpro-brain natriuretic peptide in preterm infants
10.3760/cma.j.issn.2095-428X.2015.10.022
- VernacularTitle:早产儿动脉导管未闭与B型脑钠肽及氨基末端脑钠肽前体相关性
- Author:
Min HUANG
;
Zhichun FENG
;
Jia CHEN
- Publication Type:Journal Article
- Keywords:
Patent ductus arteriosus;
B-type natriuretic peptide;
N-terminal pro-brain natriuretic peptide;
Preterm infant
- From:
Chinese Journal of Applied Clinical Pediatrics
2015;30(10):793-795
- CountryChina
- Language:Chinese
-
Abstract:
Patent ductus arteriosus(PDA) is a common condition that primarily occurs in preterm infants who with low birth weight,which closely related to several co-morbidities(intracranial hemorrhage,necrotizing enterocolitis,pulmonary edema/hemorrhage,bron chopulmonary dysplasia,and retinopathy).Although the color Doppler ultrasound assessment can be used as the gold standard to determine the present of PDA,it is still very hard to fully reflect the hemodynamic change occured in PDA case.In recent years,B-type natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-proBNP),two kind of biological markers,were used in the premature infants to assess the present,shunt volume,progress and durg or surgical intervention indication of PDA.In this paper,the corrections of PDA between BNP and NT-proBNP were reviewed briefly.
